EUVIMEDEUVIMED entdecken
Open Access

Vepdegestrant for ESR1-mutated breast cancer

Ryan S MacLeod, Chuan-Ju Liu

Trends in Pharmacological Sciences · 2026-08 · 47 (8) · 940-941

DOI: 10.1016/j.tips.2026.06.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Pharmacological Sciences, 2026-08. Verfasst von Ryan S MacLeod und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT 06510, USA; Section of Endocrinology, Diabetes and Metabolism, …. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NINDS NIH HHS, NIH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT 06510, USA; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Yale School of Medicine, New Haven, CT 06510,…
  • Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: chuan-ju.liu@yale.edu.

Förderung

  • NIAMS NIH HHS
  • NINDS NIH HHS
  • NIH

Zitieren

APA

MacLeod, R. S., & Liu, C. J. (2026). Vepdegestrant for ESR1-mutated breast cancer. Trends in Pharmacological Sciences, 47(8), 940-941. https://doi.org/10.1016/j.tips.2026.06.009

Vancouver

MacLeod RS, Liu CJ. Vepdegestrant for ESR1-mutated breast cancer. Trends in Pharmacological Sciences. 2026;47(8):940-941. doi:10.1016/j.tips.2026.06.009

BibTeX
@article{MacLeod2026,
  author = {MacLeod, Ryan S and Liu, Chuan-Ju},
  title = {Vepdegestrant for ESR1-mutated breast cancer},
  journal = {Trends in Pharmacological Sciences},
  year = {2026},
  volume = {47},
  number = {8},
  pages = {940--941},
  doi = {10.1016/j.tips.2026.06.009}
}
Kostenlos starten →